Howard W Robin Nektar Therapeutics (NKTR) insider trading activity

Howard W Robin is President & CEO of NEKTAR THERAPEUTICS. Currently has a direct ownership of 863,239 shares of NKTR, which is worth approximately $1.07 Million. The most recent transaction as insider was on May 17, 2024, when has been sold 16,650 shares (Common Stock) at a price of $1.75 per share, resulting in proceeds of $29,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 863K

1.89% 3M change

8.15% 12M change

Total Value Held $1.07 Million

HOWARD W ROBIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 17 2024	SELL Open market or private sale	$29,137 $1.75 p/Share	16,650 Reduced 1.89%	863,239 Common Stock
Feb 20 2024	SELL Open market or private sale	$13,622 $0.68 p/Share	20,033 Reduced 2.23%	879,889 Common Stock
Nov 17 2023	SELL Open market or private sale	$9,739 $0.49 p/Share	19,877 Reduced 2.16%	899,922 Common Stock
Aug 16 2023	SELL Open market or private sale	$15,598 $0.78 p/Share	19,998 Reduced 2.13%	919,799 Common Stock
May 16 2023	SELL Open market or private sale	$14,659 $0.72 p/Share	20,361 Reduced 2.12%	939,797 Common Stock
Feb 16 2023	SELL Open market or private sale	$58,905 $3.0 p/Share	19,635 Reduced 2.0%	960,158 Common Stock
Nov 16 2022	SELL Open market or private sale	$135,709 $3.57 p/Share	38,014 Reduced 3.73%	979,793 Common Stock

Aug 16 2022	SELL Open market or private sale	$65,493 $4.76 p/Share	13,759 Reduced 1.33%	1,017,807 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	-	410,625 Added 28.47%	1,031,566 Common Stock
May 16 2022	SELL Open market or private sale	$144,290 $3.95 p/Share	36,529 Reduced 5.56%	620,941 Common Stock
May 15 2022	BUY Grant, award, or other acquisition	-	68,450 Added 9.43%	657,470 Common Stock
Feb 16 2022	SELL Open market or private sale	$136,656 $10.95 p/Share	12,480 Reduced 2.07%	589,020 Common Stock
Dec 16 2021	BUY Grant, award, or other acquisition	-	126,050 Added 17.33%	601,500 Common Stock
Nov 16 2021	SELL Open market or private sale	$562,893 $13.16 p/Share	42,773 Reduced 8.25%	475,450 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	94,100 Added 15.37%	518,223 Common Stock
Aug 16 2021	SELL Open market or private sale	$159,252 $13.83 p/Share	11,515 Reduced 2.64%	424,123 Common Stock
May 17 2021	SELL Open market or private sale	$211,548 $18.3 p/Share	11,560 Reduced 2.58%	435,638 Common Stock
Feb 16 2021	SELL Open market or private sale	$257,143 $22.37 p/Share	11,495 Reduced 2.51%	447,198 Common Stock
Feb 04 2021	SELL Open market or private sale	$3,051,000 $20.34 p/Share	150,000 Reduced 24.64%	458,693 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$1,320,000 $8.8 p/Share	150,000 Added 19.77%	608,693 Common Stock
Feb 03 2021	SELL Open market or private sale	$2,958,000 $19.72 p/Share	150,000 Reduced 24.64%	458,693 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$1,320,000 $8.8 p/Share	150,000 Added 19.77%	608,693 Common Stock
Feb 02 2021	SELL Open market or private sale	$3,106,500 $20.71 p/Share	150,000 Reduced 24.64%	458,693 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$1,320,000 $8.8 p/Share	150,000 Added 19.77%	608,693 Common Stock
Dec 18 2020	BUY Grant, award, or other acquisition	-	106,650 Added 18.86%	458,693 Common Stock

HWR

Howard W Robin

President & CEO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Value

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEKTAR THERAPEUTICS

Track Activities on NKTR

Account